Dr. Cuadrado received his degree in Biology in 1982 and received his PhD in 1985 in University Complutense of Madrid. He joined the National Institutes of Health to complete his postdoctoral training in Molecular Biology with Fulbright and Fogarty fellowships (1986-90). Dr Cuadrado is tenured Professor of Biochemistry at University Autonoma of Madrid (Spain). His research group belongs to CIBERNED (Centro de Investigación en Red sobre Enfermedades Neurodegenerativas) a centre created in 2007 to carry out top-level basic and clinical research on neurodegenerative diseses, aiding in the transfer of basic research results to a clinical setting. Sine 1997, his team has been working on the understanding of molecular bases of neurodegeneration and neuroinflammation and has been searching for new pharmacological targets that might provide a neuroprotective benefit as add on therapies for Parkinson’s disease.

Dr. Cuadrado is currently Deputy Director of the Institute of Biomedical Research “Alberto Sols” UAM-CSIC. He has been awarded several research projects funded by private, local, and governmental agencies to study the molecular basis of Parkinson’s disease. He has published over 50 primary and review articles, many of them related to neuroprotection in preclinical models of Parkinson’s disease. He is grant and fellowship evaluation consultant for Spanish governmental and autonomic agencies. As a professor, Dr. Cuadrado has participated in multiple teaching activities for the carriers of biochemistry and medicine, with special focus on research training.